Phesi Global Analysis, May 2025
Leveraging Data Science
to Power
Precision Oncology
DOWNLOAD THE REPORT BELOW
Our new report examines the current state of oncology clinical development and the opportunity to leverage significant volumes of contextualized patient data to accurately profile patients, generate digital twins, accelerate clinical trials through better protocol design and investigator site selection and power precision oncology. Using Phesi’s AI-powered Trial Accelerator™ platform with data from 167 million patients, our global analysis shows colorectal cancer has the largest volume of real-world data. Read the report and discover how clinical data science can revolutionize oncology clinical development.
Key data highlights:
- The five cancers with the most available patient data
- Volumes of real-world data for each of the top five causes of cancer death
- Opportunities for greater precision in oncology clinical development
Get your copy of the full report
Get our latest content
Trial Complexity report
Our new Impact of Clinical Trial Complexity on ROI report shows overcollection of data adds months to clinical trials, increases patient burden and reduces ROI. It highlights the need for protocol design optimization and for sponsors to ensure they do not include an unnecessarily large number of outcome measures.
*New Edition* Digital Patient Profile Catalog
Now with 40 different Digital Patient Profiles including Breast Cancer with PIK3CA and Diffuse Large B Cell Lymphoma. Each profile provides an accurate picture of the patient population to enable greater precision in trial design and execution, using key demographics including age, sex, comorbidities, outcome measures and concomitant medications.
Nature Publication
Read our Nature publication to discover the potential of AI-powered digital twins to replace external control arms in clinical trials.